Navigation Links
CeNeS Pharmaceuticals plc: Update on Successful Phase III results,announced on Lead Product M6G

Further analysis of Phase III trial data underlines M6G's benefit compared to morphine in the treatment of post-operative pain

CAMBRIDGE, England, 7th March 2007 - CeNeS Pharmaceuticals plc (AIM: CEN), the Cambridge based biopharmaceutical company today announces additional data from the pivotal Phase III trial (M6G022) of M6G (morphine-6-glucuronide) in over 500 patients with post-operative pain. The preliminary data released on 20th February showed that M6G provided equivalent pain relief to morphine but induced significantly less post-operative nausea and vomiting (PONV).

Secondary Data Results

The additional secondary data now received by CeNeS shows that:

* less anti-emetic drugs (drugs used to control nausea and vomiting) were required in patients treated with M6G compared with those on morphine; and * M6G exhibited a long duration of analgesic action.

This was the first Phase III study where patients were given a complete pain management programme with M6G (rapid titration to comfort followed by PCA for up to 48 hours) and the first Phase III trial where nausea and vomiting were assessed as primary endpoints.

Management of PONV/use of anti-emetics

In addition to the clear nausea and vomiting reductions of over 25% announced last week, secondary data reveals that patients receiving M6G required over 20% less anti-emetic medication over the 0-24 hour period than those in the morphine group. This shows that not only does M6G induce significantly less nausea and vomiting than morphine, but also that the post-operative anti-emetic treatment required is considerably reduced.

The potential for reduced anti-emetic drug costs combined with the reduction in medical assistance and the improved patient comfort due to lower PONV supports CeNeS justification of a substantial price premium for M6G compared to morphine.

Drug consumption

It has been sh
'"/>




Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
2. Independent publication supports the profile of CeNeS phase II compound, CNS 5161
3. CeNeS Pharmaceuticals Plc Announces Preliminary Results for The Year Ending 31 December 2006
4. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
5. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
6. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
7. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
8. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
9. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
10. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
11. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
Post Your Comments:
(Date:5/22/2013)... , May 22, 2013  Healthcare providers ... enterprise content management (ECM) solution, for ... Information System .  These organizations identified enterprise ... and will use OnBase to optimize their ... (Logo:  http://photos.prnewswire.com/prnh/20090130/65710LOGO  ) ...
(Date:5/22/2013)... , May 22, 2013 STEPh, Inc., ... announce the launch of their web site ( ... Reports].  About STEPh Reports ... development.  Each STEPh Report assesses the ... data, projected launch year, company, and specific key issues.  ...
(Date:5/22/2013)... Ohio , May 22, 2013   Life ... health screening services announced today the creation of a ... (MCM) . MCM is a population ... to MCM,s growing list of clients. These important expanded ... costly chronic conditions earlier. Effective prevention reduces cost of ...
Breaking Medicine Technology:Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 2Three New Health Systems Integrate Hyland Software's OnBase with Meditech Hospital Information System 3Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site 2Life Line Screening and MCM Solutions for Better Health Announce New Partnership 2
... DAYTON, Ohio, Dec. 15 Robbins & Myers, Inc. (NYSE: ... its fiscal 2010 first quarter ending November 30, 2009, before the ... webcast is scheduled for Wednesday, January 6, 2010, at 2:30 ... Officer, and Christopher M. Hix, Vice President and Chief Financial Officer, ...
... , ST. LOUIS, Dec. 15 KV Pharmaceutical ... the Company received a written notice (the "Notice") executed by ... of the Company, requesting that the Board of Directors of ... action by written consent relating to the proposed appointment of ...
Cached Medicine Technology:KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 2KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 3KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 4KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 5KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 6KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent 7
(Date:5/22/2013)... 22, 2013 Phelps Memorial Hospital Center ... Westchester Lung Nodule Center for individuals who would like ... care. Lung cancer is the deadliest form of cancer for ... the U.S. die from lung cancer than from breast, colon ... early detection increases survival rates. It is well established ...
(Date:5/22/2013)... 22, 2013 Hurricane preparation isn’t just ... That’s why Amica Insurance is reminding everyone ... upcoming hurricane season. , “An important part of hurricane ... a senior assistant vice president at Amica Insurance. “The ... the threat of a storm.” , Flood damage is ...
(Date:5/22/2013)... Daytona Beach, FL (PRWEB) May 22, 2013 ... have signed on as a sponsor for this weekend's I ... will take place at 8:00 am at Cocoa Riverside Park ... the community through the I Talk to Strangers social movement. ... team of runners and walkers to participate in the event. ...
(Date:5/22/2013)... HR Strategies recently participated in the Gwinnett Relay ... on Friday May 10, 2013. For never having participated ... over $6,300 for cancer research. , HR Strategies ... first $3,000 for Bronze Level Sponsorship. HR Strategies CEO, ... match the company’s contribution of $3,000; and after just ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Unknown to the ... area at 30 mph. Minutes before it struck, the ... the nearing threat. This gave them time to reach safety ... Data is proud to provide a product that will ... A Wheelock SAFEPATH® SP40S Emergency Evacuation System provides ...
Breaking Medicine News(10 mins):Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 2Health News:Phelps Memorial Hospital Center Establishes The Westchester Lung Nodule Center To Diagnose And Administer Lung Cancer Care 3Health News:Reviewing Insurance Policies: a Key Part of Hurricane Preparations 2Health News:Space Girl Organics to Sponsor May 25 Miracle Run/Walk 2Health News:HR Strategies Raises Over $6,300 for Cancer Research via Relay For Life 2Health News:Telcom & Data Introduces Wheelock SAFEPATH® SP40S Emergency Evacuation System, An Effective Office Tool to Protect Employees from Severe Weather Threats 2
... devastating neurodegenerative disorders such as Huntington,s disease has been ... the use of cutting-edge genetic techniques. Led by ... Lisbon (led by Dr Tiago Outeiro) and University of ... collaborated to generate novel approaches for tackling the diseases. ...
... January 10, 2011 -- While most blood tests require shipping ... several days for the results, a new device invented by a ... uses just a pinprick of blood in a portable device that ... a big step in point-of-care diagnostics, where testing can be performed ...
... Steven Reinberg HealthDay Reporter , FRIDAY, Jan. 7 ... amount of fluoride in the nation,s drinking water should now ... is a significant help in preventing cavities and tooth decay, ... teeth. About two out of five teens have white spots ...
... Jenifer Goodwin HealthDay Reporter , FRIDAY, Jan. 7 (HealthDay ... skin come to mind, but new research finds that skin isn,t ... facial bones, which lose volume and recede, making you look even ... the bones of the eye socket gradually widen, the brow bone ...
... 2011) Just 5 percent of Parkinson,s disease cases can ... known cause. But a new discovery by researchers at The ... to explain why the vast majority of Parkinson,s patients develop ... Journal of Neuroscience , the researchers demystified a process that ...
... on information to predict their future health, and may be ... a national survey conducted by researchers at Tufts Medical Center, ... hypothetical predictive test to find out if they will later ... average, respondents were willing to pay $300 to $600, depending ...
Cached Medicine News:Health News:New hope in fight against Huntington's disease 2Health News:Engineering team invents lab-on-a-chip for fast, inexpensive blood tests 2Health News:U.S. Officials Recommend Reduced Fluoride Levels in Water 2Health News:Age Takes Toll on Facial Bones, Study Finds 2Health News:Age Takes Toll on Facial Bones, Study Finds 3Health News:Scientists shed light on what causes brain cell death in Parkinson's patients 2Health News:Most consumers want predictive tests to learn if a disease is in their future 2Health News:Most consumers want predictive tests to learn if a disease is in their future 3
Tips are sharp on both sides to puncture, cut and tear the capsule...
... is designed to automatically measure and display ... with heart rate. It's a Blood Pressure ... ergometer and pharmacological stress test environments. Tango ... environments., ,Tango excels where other BP ...
...
... Tamp is an orthopedic balloon designed to ... Like an angioplasty balloon, it can be ... is inflated with radiopaque contrast medium. The ... volume. The force of balloon growth compacts ...
Medicine Products: